InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the complete record of transactions filed by Moreau, Christopher. Director active across 3 companies, notably Algernon Health Inc.. In total, 21 reports have been recorded. Breakdown: 5 buys · 0 sell. Total volume traded: €87k. Activity tracked since 1 August 2024. The latest transaction was disclosed on 5 June 2026 (16 - Acquisition or disposition under a prospectus exemption). Regulator: SEDI. All data is accessible without signup.
21 条申报中的 21 条
Christopher Moreau is a declarant who has made 21 filings in total. In his most recent filings, he purchased shares of Algernon Pharmaceuticals Inc. for an amount of 33,882.30 EUR on August 2, 2024, and also bought shares of Grey Matters Health Inc. for an amount of 18,654.00 EUR on June 29, 2026. He also made an other type filing for Grey Matters Health Inc. on June 29, 2026, for an amount of 37,042.20 EUR. In total, he has invested 86,504 EUR in purchases, with no sales recorded.